FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

1,063 letters match. Newest first.

  1. AnuMed International, LLC

    FDA warned AnuMed International about unapproved drugs, misleading FDA claims, and manufacturing quality failures.

    High risk
  2. Anglo Freight USA Inc.

    Illinois food importer Anglo Freight USA lacked FSVP records for flour, kumis, seabuckthorn juice and teas, and never registered its facility.

    Medium
  3. CARsgen Therapeutics Corporation

    FDA warns CARsgen over CGMP violations for investigational CAR T cell products at Durham facility.

    High risk
  4. Minland of Texas, Inc.

    FDA warned Minland of Texas that it lacked a required Foreign Supplier Verification Program for imported peanut gluten, soy sauce, and rice vinegar.

    Medium
  5. Berkeley Biologics, LLC, previously operating as Elutia, Inc. – Orthobiologics Business Unit, formerly Aziyo Biologics, Inc.

    FDA says Berkeley Biologics' viable bone matrix products are unapproved drugs, with donor screening failures tied to tuberculosis infections.

    High risk
  6. Eugia Pharma Specialities Limited

    FDA cited Eugia Pharma Specialities for CGMP violations at its India sterile injectable plant, including falsified records and contamination risks.

    High risk
  7. Intercos Europe S.p.A

    FDA warned Intercos Europe S.p.A over current good manufacturing practice violations in OTC sunscreen drugs, including missing glycerin DEG/EG testing and poor investigations.

    High risk
  8. AUSTROFOOD S.A.S.

    Austrofood's apple cinnamon puree pouches were adulterated with extremely high lead from cinnamon; hazard controls failed.

    High risk
  9. Nowrez & Ismail Shukri Company

    FDA warns Jordanian OTC drug maker Nowrez & Ismail Shukri over CGMP violations and import alert.

    High risk
  10. Central Admixture Pharmacy Services, Inc.

    FDA warns Central Admixture Pharmacy Services over sterile compounded drugs, contamination risks, and quality failures at its San Diego site.

    High risk
  11. Guangzhou Baiyunshan Jingxiutang Pharmaceutical Co. Ltd.

    FDA warned Guangzhou Baiyunshan Jingxiutang Pharmaceutical over current good manufacturing practice violations in over-the-counter drug manufacturing, including inadequate specs and microbial testing.

    High risk
  12. Omega Tech Labs LLC

    Omega Tech Labs in Boise, Idaho, released microbially contaminated combination drug-device product and failed manufacturing rules.

    High risk
  13. Velocity Pharma LLC

    Velocity Pharma distributed eye drop drugs made by contract manufacturers with serious manufacturing and sanitation violations.

    High risk
  14. Corporacion Avicola Morovis Inc

    FDA warns Corporacion Avicola Morovis over Salmonella prevention failures at its Puerto Rico shell egg farm.

    High risk
  15. Brassica Pharma Pvt. Ltd.

    FDA warns Brassica Pharma over fabricated sterility and environmental data and poor aseptic controls for sterile drugs.

    High risk
  16. Formulation Technology, Inc.

    FDA warns Formulation Technology over unapproved migraine supplement claims and manufacturing/labeling violations.

    High risk
  17. Genuine Virgin Aloe Corp dba Triderma

    FDA warned Triderma, an Anaheim OTC skin cream maker, of CGMP violations after a January 2024 inspection.

    High risk
  18. Key Foods Co. dba Key Food Services

    FDA warned Key Foods Co. dba Key Food Services that it lacked required Foreign Supplier Verification Program plans for several imported foods.

    Medium
  19. ARG Laboratories, Inc.

    FDA found ARG Laboratories released failing over-the-counter drug lots, lacked manufacturing controls, and marketed two unapproved pain creams.

    High risk
  20. Art of Beauty Company, Inc.

    FDA warned Art of Beauty over manufacturing-rule violations in OTC hand sanitizer, including missing component and finished-product testing.

    High risk
  21. Natural Ginger, Corp/Jonaus Corp

    FDA warned Natural Ginger that it markets six syrups and supplements as unapproved new drugs with disease-treatment claims on its website.

    Medium
  22. Optikem International Inc.

    FDA warns Optikem International after inspection found inadequate aseptic controls for sterile ophthalmic drugs, including contamination and validation failures.

    High risk
  23. Laboratorio Magnachem International

    FDA cited Laboratorio Magnachem for CGMP failures and unapproved, misbranded Broncochem cough/cold drugs after a 2023 inspection.

    High risk
  24. PepsiCo, Inc.

    FDA warned PepsiCo after Salmonella Cubana was found at its Danville, Illinois Quaker Oats plant, prompting recalls of granola bars and cereals.

    High risk
  25. Sun Pharmaceutical Industries Limited

    FDA cited Sun Pharmaceutical Industries for inadequate cleaning and maintenance at its Dadra drug plant, risking cross-contamination, and for weak investigations.

    High risk
  26. Frozen Food Development, Inc.

    Frozen Food Development packed ready-to-eat frozen produce under rodent activity and lacked required pathogen controls.

    High risk
  27. GFA Production Xiamen Co., Ltd.

    GFA Production Xiamen failed CGMP for drugs, including process validation, cleaning, and lab controls.

    High risk
  28. Landy International

    FDA found Landy International’s OTC hand sanitizers adulterated after a 2023 inspection revealed missing testing, unsafe water, and data integrity failures.

    High risk
  29. Aqualex Co., Ltd.

    Aqualex, a Korean contract manufacturer, was cited for manufacturing failures and an unapproved OTC sunscreen with misleading labeling.

    High risk
  30. Dollar Tree Inc.

    Dollar Tree continued offering recalled WanaBana apple cinnamon puree pouches with extremely high lead levels, FDA says.

    High risk
  31. Neobiosis, LLC

    FDA warns Neobiosis over unapproved amniotic fluid and umbilical cord products and serious manufacturing quality failures.

    High risk
  32. TCT Nutraceuticals SDN. BHD

    FDA warns TCT Nutraceuticals over manufacturing-rule failures in OTC hand sanitizer, including no methanol testing.

    High risk
  33. Cosmetic Solutions, LLC

    FDA warns Cosmetic Solutions over manufacturing failures and unapproved OTC drugs at Boca Raton plant.

    High risk
  34. All Things Bunnies, Inc.

    All Things Bunnies markets Toltrazuril 5% Suspension as an unapproved new animal drug for coccidiosis.

    Medium
  35. Baja Best Distributing, Inc.

    Baja Best Distributing lacked required FSVP for imported fresh cucumbers and strawberries from Mexico, FDA says.

    Medium
  36. Techlem Medical Corporation

    Techlem Medical Corporation failed quality and unique device identifier requirements for wheeled stretchers, FDA says.

    Medium
  37. Genpro Imports & Export Inc.

    FDA warns Genpro Imports over missing FSVP records for imported produce and ginger.

    Medium
  38. Aruba Aloe Balm N.V.

    Aruba Aloe Balm N.V. made OTC drugs with methanol-contaminated ethanol and failed CGMP, prompting recall and import alert.

    High risk
  39. Biomic Sciences, LLC dba ION Intelligence of Nature

    Biomic Sciences' nasal spray was grossly contaminated with microorganisms, and FDA also found manufacturing and labeling violations.

    High risk
  40. Amin Trading Agency LLC

    FDA found Amin Trading Agency lacked required foreign supplier checks for imported Indian spice products, including Everest and Masala E Magic.

    Medium
  41. Rash Catering Services, LLC

    FDA warns Houston importer Rash Catering for having no FSVP for its imported flours and biscuits.

    Medium
  42. Seatex, LLC

    FDA: Seatex made hand sanitizer on equipment also used for floor cleaner and skipped ingredient identity tests.

    High risk
  43. Central Admixture Pharmacy Services, Inc.

    FDA warned sterile drug compounder Central Admixture Pharmacy Services (Phoenix) that dirty areas and weak sterility testing made its drugs adulterated.

    High risk
  44. Meditco, Inc. D.B.A. Phoenicia Specialty Foods

    FDA says Meditco, a Houston food importer, lacked FSVP records for chickpeas, falafel spices, and rose syrup.

    Medium
  45. Ocean Group Inc.

    Ocean Group Inc.'s ready-to-eat salmon and tuna were tied to Listeria monocytogenes and insanitary conditions after an FDA inspection.

    High risk
  46. Westwood Laboratories LLC

    FDA warned Westwood Laboratories after an inspection found inadequate investigations, raw material testing, lab controls, and water/cleaning controls for OTC drugs.

    High risk
  47. Cohere Beauty

    FDA cites Cohere Beauty for unvalidated OTC drug manufacturing and inadequate quality oversight at its Santa Fe Springs facility.

    Medium
  48. Hacienda Mexican Foods, LLC

    FDA warns Hacienda Mexican Foods of Salmonella risk and missing controls in ready-to-eat tortillas.

    High risk
  49. Seatex, LLC

    Seatex, LLC made OTC hand sanitizer drugs with inadequate current good manufacturing practice (CGMP), including shared equipment with industrial chemicals and missing component testing.

    High risk
  50. Central Admixture Pharmacy Services, Inc.

    FDA warned Central Admixture Pharmacy Services' Allentown outsourcing facility over sterile drug contamination and CGMP failures.

    High risk